Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qun Luo

Showing results (601-610 of 636) with videos related to

Pageof 64
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Establishment of genotyping method for fetal ABO group from pregnant maternal peripheral blood]Yang Yu, Qian Fen, Zi-Lin Lin, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical TrialLi Xiang, Jian-Wen Zhang, Sheng Lin, et al.
BMC Cancer|January 13, 2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocolXin-Yu Li, Jia-Qiang Li, Xue-Qun Luo, et al.
Oncotarget|February 27, 2016
Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathwayYan-Lai Tang, Li-Bin Huang, Wen-Hao Lin, et al.
The EMBO Journal|February 2, 2026
RBM15B recognizes H3K79me2 to guide selective m<sup>6</sup>A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemiaTian-Qi Chen, Yu-Meng Sun, Shun-Xin Zhu, et al.
Infectious Diseases and Therapy|June 26, 2021
A Prospective Study of Etiological Agents Among Febrile Patients in Sierra LeoneHan Wang, Jing Zhao, Na Xie, et al.
Kidney Diseases (Basel, Switzerland)|April 21, 2025
Sacubitril-Valsartan Lowers Blood Pressure in Patients on Dialysis: A Randomized Controlled Multicenter StudyLi Lin, Weijing Bian, Qun Luo, et al.
Annals of Hematology|May 18, 2023
Differentiation syndrome and coagulation disorder - comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemiaJie-Si Luo, Xiao-Li Zhang, Dan-Ping Huang, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2022
The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemiaLiu-Hua Liao, Yi-Qiao Chen, Dan-Ping Huang, et al.
Pageof 64

Showing results (601-610 of 636) with videos related to

Sort By:
Pageof 64
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 21, 2009
[Establishment of genotyping method for fetal ABO group from pregnant maternal peripheral blood]Yang Yu, Qian Fen, Zi-Lin Lin, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical TrialLi Xiang, Jian-Wen Zhang, Sheng Lin, et al.
BMC Cancer|January 13, 2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocolXin-Yu Li, Jia-Qiang Li, Xue-Qun Luo, et al.
Oncotarget|February 27, 2016
Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathwayYan-Lai Tang, Li-Bin Huang, Wen-Hao Lin, et al.
The EMBO Journal|February 2, 2026
RBM15B recognizes H3K79me2 to guide selective m<sup>6</sup>A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemiaTian-Qi Chen, Yu-Meng Sun, Shun-Xin Zhu, et al.
Infectious Diseases and Therapy|June 26, 2021
A Prospective Study of Etiological Agents Among Febrile Patients in Sierra LeoneHan Wang, Jing Zhao, Na Xie, et al.
Kidney Diseases (Basel, Switzerland)|April 21, 2025
Sacubitril-Valsartan Lowers Blood Pressure in Patients on Dialysis: A Randomized Controlled Multicenter StudyLi Lin, Weijing Bian, Qun Luo, et al.
Annals of Hematology|May 18, 2023
Differentiation syndrome and coagulation disorder - comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemiaJie-Si Luo, Xiao-Li Zhang, Dan-Ping Huang, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2022
The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemiaLiu-Hua Liao, Yi-Qiao Chen, Dan-Ping Huang, et al.
Pageof 64